AQUESTIVE THERAPEUTICS
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
AQUESTIVE THERAPEUTICS
Industry:
Pharmaceutical
Founded:
2004-01-15
Address:
Warren, New Jersey, United States
Country:
United States
Website Url:
http://www.aquestive.com
Total Employee:
101+
Status:
Active
Contact:
908-941-1900
Email Addresses:
[email protected]
Total Funding:
368.06 M USD
Technology used in webpage:
Domain Not Resolving SPF Amazon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS ASP.NET IIS IIS 10
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Immuneering
Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Aquestive Therapeutics
Madryn Asset Management
Madryn Asset Management investment in Post-IPO Debt - Aquestive Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Debt Financing - Aquestive Therapeutics
Edward P. Bass Group
Edward P. Bass Group investment in Debt Financing - Aquestive Therapeutics
CNF Investments, LLC
CNF Investments, LLC investment in Debt Financing - Aquestive Therapeutics
Halifax Group
Halifax Group investment in Debt Financing - Aquestive Therapeutics
White Oak Global Advisors
White Oak Global Advisors investment in Debt Financing - Aquestive Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-06-29 | Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment |
Official Site Inspections
http://www.aquestive.com Semrush global rank: 5.15 M Semrush visits lastest month: 1.53 K
- Host name: cloudproxy10104.sucuri.net
- IP address: 192.124.249.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aquestive Therapeutics"
Home | Aquestive Therapeutics
Aquestive is a pharmaceutical company aiming to solve patients’ problems by advancing current standards of care through simplifying complex delivery methods. Aquestive is developing …See details»
About Us | Aquestive Therapeutics
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …See details»
Corporate Governance - Aquestive Therapeutics
Dan Barber was appointed Chief Executive Officer, President and as a member of our Board on May 17, 2022, after having served as our Chief Operating Officer since May 2019. Daniel …See details»
Aquestive Therapeutics - Crunchbase Company Profile & Funding
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve …See details»
Aquestive Therapeutics Strengthens Board of Directors with …
Aquestive’s Board of Directors will now be comprised of eight Directors, seven of whom are independent. Dr. Krop will serve as a member of the Board’s Nominating and Corporate …See details»
Daniel Barber - CEO, President & Director at Aquestive ... - The Org
Daniel Barber joined Aquestive in July 2007. Prior to joining Aquestive, Mr. Barber held various positions with Quest Diagnostics in their corporate planning and international divisions. Over …See details»
Aquestive Therapeutics - LinkedIn
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to...See details»
Investor Relations - Aquestive Therapeutics
Oct 18, 2024 · Aquestive is developing orally administered products to provide novel alternatives to invasive and inconvenient standard of care therapies. Our focus is to improve medications …See details»
Aquestive Therapeutics Announces CEO Transition
May 17, 2022 · Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an earlier stage pipeline for the …See details»
Aquestive Therapeutics Announces Executive Appointments and …
Jun 3, 2024 · Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system and an earlier stage pipeline for the treatment of …See details»
Our Responsibility - Aquestive
Aquestive is committed to conducting our business with the highest ethical standards. The Company's commitment to ethics and good corporate citizenship is grounded in our compliance with laws and regulations that govern the way …See details»
Pharmanovia expands exclusive licensing collaboration with …
Mar 29, 2023 · Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of established medicines, has today announced that it has expanded its …See details»
What is Aquestive? Company Culture, Mission, Values
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve …See details»
Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 ...
Dec 31, 2022 · Aquestive is advancing the development of AQST-109, the first and only orally delivered epinephrine product candidate to demonstrate clinical results comparable to …See details»
Aquestive Therapeutics: Anaphylm’s Top-Line Data Could Reveal A …
Jan 19, 2024 · Aquestive Therapeutics is nearing a key topline readout for its Anaphylm sublingual film, a potential groundbreaking oral epinephrine treatment for severe allergic …See details»
Aquestive Therapeutics Corporate Presentation
Property of Aquestive Therapeutics, Inc. June2019 Corporate Highlights 3 Advancing a late-stage pipeline that features promising treatments for patients and caregivers living with complex …See details»
Aquestive Reviews: What Is It Like to Work At Aquestive?
61 Aquestive reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
Aquestive Therapeutics Corporate Presentation
LibervantTM Buccal Film (Diazepam) is an investigational drug being evaluated for use in children and adults with refractory seizures, who remain on stable regimens of antiepileptic drugs, to …See details»
Aquestive Reviews: What Is It Like to Work At Aquestive?
Apr 4, 2024 · Aquestive has an overall rating of 2.9 out of 5, based on over 64 reviews left anonymously by employees. 44% of employees would recommend working at Aquestive to a …See details»
Anaphylmâ„¢ - Aquestive
Aquestive recognizes the need for an oral formulation of epinephrine and is leveraging its proprietary PharmFilm ® technology to develop this treatment. Anaphylaxis is a serious …See details»